Correlation Between Verrica Pharmaceuticals and COSCIENS Biopharma
Can any of the company-specific risk be diversified away by investing in both Verrica Pharmaceuticals and COSCIENS Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verrica Pharmaceuticals and COSCIENS Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verrica Pharmaceuticals and COSCIENS Biopharma, you can compare the effects of market volatilities on Verrica Pharmaceuticals and COSCIENS Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verrica Pharmaceuticals with a short position of COSCIENS Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verrica Pharmaceuticals and COSCIENS Biopharma.
Diversification Opportunities for Verrica Pharmaceuticals and COSCIENS Biopharma
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Verrica and COSCIENS is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and COSCIENS Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COSCIENS Biopharma and Verrica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verrica Pharmaceuticals are associated (or correlated) with COSCIENS Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COSCIENS Biopharma has no effect on the direction of Verrica Pharmaceuticals i.e., Verrica Pharmaceuticals and COSCIENS Biopharma go up and down completely randomly.
Pair Corralation between Verrica Pharmaceuticals and COSCIENS Biopharma
Given the investment horizon of 90 days Verrica Pharmaceuticals is expected to generate 3.03 times more return on investment than COSCIENS Biopharma. However, Verrica Pharmaceuticals is 3.03 times more volatile than COSCIENS Biopharma. It trades about 0.03 of its potential returns per unit of risk. COSCIENS Biopharma is currently generating about -0.26 per unit of risk. If you would invest 143.00 in Verrica Pharmaceuticals on September 4, 2024 and sell it today you would lose (15.00) from holding Verrica Pharmaceuticals or give up 10.49% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 95.24% |
| Values | Daily Returns |
Verrica Pharmaceuticals vs. COSCIENS Biopharma
Performance |
| Timeline |
| Verrica Pharmaceuticals |
| COSCIENS Biopharma |
Verrica Pharmaceuticals and COSCIENS Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verrica Pharmaceuticals and COSCIENS Biopharma
The main advantage of trading using opposite Verrica Pharmaceuticals and COSCIENS Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verrica Pharmaceuticals position performs unexpectedly, COSCIENS Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COSCIENS Biopharma will offset losses from the drop in COSCIENS Biopharma's long position.| Verrica Pharmaceuticals vs. Inventiva Sa | Verrica Pharmaceuticals vs. Edgewise Therapeutics | Verrica Pharmaceuticals vs. Vigil Neuroscience | Verrica Pharmaceuticals vs. Connect Biopharma Holdings |
| COSCIENS Biopharma vs. Candel Therapeutics | COSCIENS Biopharma vs. Cingulate Warrants | COSCIENS Biopharma vs. Unicycive Therapeutics | COSCIENS Biopharma vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |